ABT

2026Q1BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2026-04-16 · Fiscal end 2026-03-31 · Features as of 2026-04-15

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.15
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.5%
IV front—
P/C full—
P/C front—
Features as of2026-04-15

Run-up

Close—
Ret 5d-1.9%
Ret 10d-1.1%
Ret 20d-8.3%
Ret 30d-10.6%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.15—
Estimated EPS1.15
Actual revenue
11.2B
Surprise %0.0%
Beat / miss—
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction-1.7%
Implied vs actual

Implied 4.5%Actual 4.4%

Gap reaction-4.4%
Day result-6.0%
Next-day upNo
Realized / IV0.96×

Post tape

Post 5d-3.1%
Post 10d-4.9%
Post volume27.8M
Vol ×10d2.88×
Vol ×20d2.11×
Post range5.2%